Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Kategoria artykułu: Research Article

Data publikacji: 21 lut 2018

Zakres stron: 281 - 288

Otrzymano: 22 lis 2017

Przyjęty: 30 lis 2017

DOI: https://doi.org/10.2478/raon-2018-0009

Słowa kluczowe

locally advanced NSCLC, survival, immunotherapy, PD-L1 expression, chemoradiotherapy

© 2018 Martina Vrankar, Karmen Stanic, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.